These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 19404973)

  • 21. Rosuvastatin in the primary prevention of cardiovascular disease among patients with low levels of low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: rationale and design of the JUPITER trial.
    Ridker PM;
    Circulation; 2003 Nov; 108(19):2292-7. PubMed ID: 14609996
    [No Abstract]   [Full Text] [Related]  

  • 22. Rosuvastatin in patients with elevated C-reactive protein.
    Pierard LA
    N Engl J Med; 2009 Mar; 360(10):1040; author reply 1041-2. PubMed ID: 19271277
    [No Abstract]   [Full Text] [Related]  

  • 23. High-sensitivity C-reactive protein in every chart? The use of biomarkers in individual patients.
    Ben-Yehuda O
    J Am Coll Cardiol; 2007 May; 49(21):2139-41. PubMed ID: 17531664
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A response to 'statin therapy: a potentially useful peri-operative intervention in patients with cardiovascular disease'.
    Powell B
    Anaesthesia; 2006 Mar; 61(3):307; author reply 308. PubMed ID: 16480377
    [No Abstract]   [Full Text] [Related]  

  • 25. The role of C-reactive protein (CRP) and statin treatment in reducing cardiovascular risk.
    Chin J
    S D Med; 2009 Mar; 62(3):104-6. PubMed ID: 19480274
    [No Abstract]   [Full Text] [Related]  

  • 26. Relation of C-reactive protein and one-year survival after acute myocardial infarction with versus without statin therapy.
    Kinjo K; Sato H; Sakata Y; Nakatani D; Mizuno H; Shimizu M; Nishino M; Ito H; Tanouchi J; Nanto S; Hori M;
    Am J Cardiol; 2005 Sep; 96(5):617-21. PubMed ID: 16125481
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beneficial action of statins in patients with rheumatoid arthritis in a large observational cohort.
    Okamoto H; Koizumi K; Kamitsuji S; Inoue E; Hara M; Tomatsu T; Kamatani N; Yamanaka H
    J Rheumatol; 2007 May; 34(5):964-8. PubMed ID: 17444591
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipid screening and statins alongside disease-modifying anti-rheumatic drugs for patients with rheumatoid arthritis.
    Navarro-Millán I; Goyal P; Safford MM
    Rheumatology (Oxford); 2019 Jun; 58(6):933-934. PubMed ID: 30272226
    [No Abstract]   [Full Text] [Related]  

  • 29. A response to 'statin therapy: a potentially useful peri-operative intervention in patients with cardiovascular disease'.
    Maharaj R
    Anaesthesia; 2006 Mar; 61(3):307-8; author reply 308. PubMed ID: 16480376
    [No Abstract]   [Full Text] [Related]  

  • 30. Primary prevention of vascular events in patients with high levels of C-reactive protein: the JUPITER study.
    Fonseca FA; Izar MC
    Expert Rev Cardiovasc Ther; 2009 Sep; 7(9):1041-56. PubMed ID: 19764857
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Statin therapy in patients with type 2 diabetes.
    Lo V; Noviasky J; Nashelsky J
    Am Fam Physician; 2005 Sep; 72(5):866-8. PubMed ID: 16156346
    [No Abstract]   [Full Text] [Related]  

  • 32. JUPITER study highlights C-reactive protein as a cardiac risk factor.
    Cardiovasc J Afr; 2009; 20(2):146. PubMed ID: 19421655
    [No Abstract]   [Full Text] [Related]  

  • 33. Prevalence of low low-density lipoprotein cholesterol with elevated high sensitivity C-reactive protein in the U.S.: implications of the JUPITER (Justification for the Use of Statins in Primary Prevention: An Intervention Trial Evaluating Rosuvastatin) study.
    Michos ED; Blumenthal RS
    J Am Coll Cardiol; 2009 Mar; 53(11):931-5. PubMed ID: 19281922
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Less vascular risk with rosuvastatin in elevated CRP].
    Bredie B
    Ned Tijdschr Geneeskd; 2009 Feb; 153(6):245. PubMed ID: 19271446
    [No Abstract]   [Full Text] [Related]  

  • 35. Are high-risk hypertensive patients being prescribed concomitant statin therapy?: a retrospective cohort study.
    Chapman RH; Petrilla AA; Berman L; Benner JS; Tang SS
    Am J Cardiovasc Drugs; 2009; 9(5):299-308. PubMed ID: 19791839
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A triumvirate of targets in the prevention and treatment paradigm for cardiovascular disease.
    Packard C
    Atheroscler Suppl; 2006 Apr; 7(1):21-9. PubMed ID: 16504600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The JUPITER trial: How will it change clinical practice?
    Watson KE
    Rev Cardiovasc Med; 2009; 10(2):91-6. PubMed ID: 19593321
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low-risk older patients (50 years and older) with raised high-sensitivity CRP (hs-CRP) benefit from rosuvastatin therapy: the JUPITER study.
    Cardiovasc J Afr; 2008; 19(6):332-4, discussion 335. PubMed ID: 19104734
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of withdrawal of pravastatin therapy on C-reactive protein and low-density lipoprotein cholesterol.
    van der Harst P; Asselbergs FW; Hillege HL; Bakker SJ; Voors AA; van Veldhuisen DJ; van Gilst WH;
    Am J Cardiol; 2007 Nov; 100(10):1548-51. PubMed ID: 17996517
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does statin therapy improve cardiovascular outcomes in patients with type 2 diabetes receiving hemodialysis?
    Kwan BC; Beddhu S; Kronenberg F; Cheung AK
    Nat Clin Pract Nephrol; 2006 Feb; 2(2):76-7. PubMed ID: 16932397
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.